Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
JIM CRAMER
Jim Cramer Says Remain Cautious: Mad Money Recap
By Scott Rutt
May 20, 2020 10:14 AM EDT
PRESS RELEASES
Athersys Announces Three Appointments To Board Of Directors
By Business Wire
Nov 16, 2020 6:00 AM EST
PRESS RELEASES
FDA Grants RMAT Designation To MultiStem Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome
By Business Wire
Sep 23, 2020 6:00 AM EDT
JIM CRAMER
Jim Cramer Says Remain Cautious: Mad Money Recap
By Scott Rutt
May 20, 2020 10:14 AM EDT
PRESS RELEASES
Athersys Announces Upcoming Presentations At The International Society Of Cell And Gene Therapy Virtual Conference
By Business Wire
May 18, 2020 6:00 AM EDT
PRESS RELEASES
Athersys And University Hospitals Cleveland Medical Center Announce Activation Of The First Clinical Site For The MACOVIA Study, A Pivotal Phase 2/3 Study Evaluating MultiStem® Cell Therapy For COVID-19 Induced ARDS
By Business Wire
May 1, 2020 6:00 AM EDT
PRESS RELEASES
Athersys To Present At The Bank Of America Merrill Lynch Virtual Healthcare Conference On May 14
By Business Wire
Apr 29, 2020 2:47 PM EDT
PRESS RELEASES
Athersys Announces Closing Of Public Offering Of Common Stock
By Business Wire
Apr 20, 2020 4:05 PM EDT
PRESS RELEASES
Athersys Announces Pricing Of Public Offering Of Common Stock
By Business Wire
Apr 15, 2020 9:33 PM EDT
PRESS RELEASES
Athersys Announces Proposed Public Offering Of Common Stock
By Business Wire
Apr 15, 2020 4:27 PM EDT
PRESS RELEASES
FDA Authorizes Initiation Of A Phase 2 Trial Evaluating MultiStem® Cell Therapy In Trauma Patients
By Business Wire
Apr 15, 2020 6:00 AM EDT
PRESS RELEASES
FDA Authorizes Athersys To Initiate A Pivotal Clinical Trial Evaluating MultiStem® Cell Therapy In Patients With COVID-19 Induced Acute Respiratory Distress Syndrome
By Business Wire
Apr 13, 2020 6:00 AM EDT
PRESS RELEASES
Athersys Names Maia Hansen Senior Vice President, Operations And Supply Chain
By Business Wire
Mar 19, 2020 6:00 AM EDT
PRESS RELEASES
Athersys Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
By Business Wire
Feb 3, 2020 6:00 AM EST
PRESS RELEASES
Athersys Names Ivor Macleod Chief Financial Officer
By GlobeNewswire
Jan 15, 2020 6:00 AM EST
MARKETS
Athersys (ATHX) Strong On High Relative Volume Today
By TheStreet Wire
Mar 24, 2016 10:09 AM EDT
STOCKS
Should You Buy Into Athersys’ Latest Spin on Failed Stroke Therapy?
By Adam Feuerstein
Feb 19, 2016 9:05 AM EST
MARKETS
Here’s Why Athersys (ATHX) Stock is Jumping Today
By Kaya Yurieff
Feb 18, 2016 1:06 PM EST
MARKETS
Athersys (ATHX) Stock Advances on Healios Licensing Agreement
By Amanda Albright
Jan 8, 2016 12:57 PM EST
OPINION
5 Breakout Stocks Under $10 Set to Soar
By Roberto Pedone
Sep 17, 2015 7:13 AM EDT
MARKETS
Insider Trading Alert - TASR, ATHX And GEO Traded By Insiders
By TheStreet Wire
Jun 11, 2015 11:45 AM EDT
MARKETS
Athersys (ATHX) Stock Continues to Decline Today on Stroke Therapy Trial Results
By Andrew Meola
Apr 20, 2015 11:05 AM EDT
MARKETS
Athersys (ATHX) Stock Plummets to 52-Week Low as Stroke Therapy Fails Mid-Stage Trial
By Andrew Meola
Apr 17, 2015 12:22 PM EDT
MARKETS
Athersys (ATHX) Highlighted As Weak On High Volume
By Marissa Goodbody
Apr 15, 2015 11:29 AM EDT
MARKETS
Trade-Ideas: Athersys (ATHX) Is Today's Strong On High Relative Volume Stock
By David M. Aferiat
Apr 13, 2015 10:02 AM EDT
